Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Kevin L Law"'
Autor:
Yangwei J. Pu, Everett J. Perkins, William D. Diseroad, David M. Bender, Anne H. Dantzig, Jeffrey A. Peterson, Deyi Zhang, Jingqi Bao, Kevin L. Law, Radhe K. Vaid, Nicholas A. Magnus, David Michael Remick, Mccarthy James R, Gregory A. Stephenson, Susan M. Reutzel-Edens, James J. Starling
Publikováno v:
Journal of Medicinal Chemistry. 52:6958-6961
The design, synthesis, and biological characterization of an orally active prodrug (3) of gemcitabine are described. Additionally, the identification of a novel co-crystal solid form of the compound is presented. Valproate amide 3 is orally bioavaila
Autor:
Tracy D. Self, Peter Ambrose Lander, Bryan H. Norman, Louis Nickolaus Jungheim, Jeffrey Daniel Cohen, Joseph Michael Gruber, Donald C. Paul, James J. Starling, Julian Stanley Kroin, Linda B. Tabas, Anne H. Dantzig, Daniel C. Williams, Kevin L. Law
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 15:5526-5530
Structure–activity relationship (SAR) studies on the tricyclic isoxazole series of MRP1 modulators have resulted in the identification of potent and selective inhibitors containing cyclohexyl-based linkers. These studies ultimately identified compo
Autor:
James P. Sluka, Robert L. Shepard, Kenneth Lee Hauser, Anne H. Dantzig, James J. Starling, Alan David Palkowitz, Bryan H. Norman, Julian Stanley Kroin, Kevin L. Law, Mark A. Winter, Linda B. Tabas
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 9:3381-3386
The benzothiophene LY329146 reverses the drug resistance phenotype in multidrug resistance protein (MRP1)-overexpressing cells when dosed in combination with MRP1-associated oncolytics doxorubicin and vincristine. Additionally, LY329146 inhibited MRP
Autor:
Kevin L. Law, James J. Starling, Damon L. Meyer, Roberto Fagnani, Michael S. Hagan, Stephen D. Mikolajczyk
Publikováno v:
Bioconjugate Chemistry. 7:150-158
The physical and pharmacological properties of proteins can be altered by chemical modification with polymers. Preliminary studies showed that attachment of oxidized dextran to the bacterial protein, beta-lactamase (beta L) effectively reduced in viv
Autor:
William J. Ehlhardt, John M. Mastro, Vinod F. Patel, Julie N. Hardin, James J. Starling, Kevin L. Law, Zimmermann John Lyle, Joseph M. Woodland
Publikováno v:
Bioconjugate Chemistry. 7:497-510
LY207702 (1) is a difluorinated purine nucleoside that exhibits impressive antitumor activity in preclinical models. This agent, however, also possesses cardiotoxicity which limits the potential cl...
Autor:
Jose Eduardo Lopez, James H Wikel, Mary Margaret Mader, Beth A Hollister, Luisa M Martin Cabrejas, Beverly Teicher, James A Aikins, Enrique Alvarez, Philip A Hipskind, Deborah D Giera, Michael E Richett, Rafael Ferritto, Karen L Lobb, Denis J. McCann, Gregory L Durst, Wesley T White, Alfonso De Dios, Cora Sue Grossman, John E. Reilly, Eileen L Considine, Victoriano Molero, Shih Chuan, Tiechao Li, Ho-Shen Lin, Beatriz Lopez, Zhongping Huang, Philip W Iversen, Yiu-Yin Cheung, Kevin L Law
Publikováno v:
Journal of medicinal chemistry. 47(22)
Two closely related diaryl acylsulfonamides were recently reported as potent antitumor agents against a broad spectrum of human tumor xenografts (colon, lung, breast, ovary, and prostate) in nude mice. Especially intriguing was their activity against
Autor:
James J. Starling, Donald C. Paul, Anne H. Dantzig, Margaret M. Wagner, Kevin L. Law, Daniel C. Williams, Linda B. Tabas, Bryan H. Norman, Tracy D. Self, Sean P. Hollinshead, Joseph W. Wilson, Joseph Michael Gruber
Publikováno v:
Bioorganicmedicinal chemistry letters. 12(6)
Tricyclic isoxazoles were identified from a screen as a novel class of selective multidrug resistance protein (MRP1) inhibitors. From a screen lead, SAR efforts resulted in the preparation of LY 402913 (9h), which inhibits MRP1 and reverses drug resi
Autor:
William F. Elmquist, Jin Cao, William J. Ehlhardt, Bryan H. Norman, Anne H. Dantzig, Michael Gregory Bell, Chuan Shih, James J. Starling, Joseph Michael Gruber, Todd M. Baughman, Mark A. Winter, Kevin L. Law, Julian Stanley Kroin, Robert L. Shepard
Publikováno v:
Advances in enzyme regulation. 37
The above data indicate that LY335979 displays the following characteristics of an 'ideal modulator' of Pgp-mediated multidrug resistance: high affinity binding to Pgp, high potency for in vitro reversal of drug resistance, high therapeutic index (ac
Autor:
Janice K. Payne, James J. Starling, Hamideh Zarrinmayeh, Stephen D. Mikolajczyk, Kevin L. Law, Timothy Alan Shepherd, Damon L. Meyer, James K. Kling, Louis Nickolaus Jungheim
Publikováno v:
Bioconjugate chemistry. 6(4)
Antibody directed catalysis (ADC), the catalytic conversion of prodrugs to drugs by enzymes localized at disease targets by appropriate monoclonal antibodies, has shown promise in the treatment of cancer in nude mouse xenograft models. We investigate
Autor:
David M. Bender, Jingqi Bao, Anne H. Dantzig, William D. Diseroad, Kevin L. Law, Nicholas A. Magnus, Jeffrey A. Peterson, Everett J. Perkins, Yangwei J. Pu, Susan M. Reutzel-Edens, David M. Remick, James J. Starling, Gregory A. Stephenson, Radhe K. Vaid, Deyi Zhang, James R. McCarthy
Publikováno v:
Journal of Medicinal Chemistry; Nov2009, Vol. 52 Issue 22, p6958-6961, 4p